EMT in cervical cancer: its role in tumour progression and response to therapy

R Qureshi, H Arora, MA Rizvi - Cancer letters, 2015 - Elsevier
The prognosis of cervical patients significantly decreases as the cancer metastasizes to
other parts of the body. The epithelial to mesenchymal transition (EMT) plays an important …

[HTML][HTML] Epithelial-mesenchymal transition in cervical carcinoma

MY Lee, MR Shen - American journal of translational research, 2012 - ncbi.nlm.nih.gov
During the progression of epithelial cancer, cells usually lose epithelial characteristic
features and gain a mesenchymal phenotype. Cervical cancer is a common female …

[HTML][HTML] Upregulation of vimentin and aberrant expression of E-cadherin/β-catenin complex in oral squamous cell carcinomas: correlation with the clinicopathological …

LK Liu, XY Jiang, XX Zhou, DM Wang, XL Song… - Modern Pathology, 2010 - Elsevier
Oral squamous cell carcinoma is a challenging oncology problem. A reliable biomarker for
metastasis or high-risk prognosis in oral cancer patients remains undefined. Using …

Epithelial-mesenchymal transition in cervical cancer: correlation with tumor progression, epidermal growth factor receptor overexpression, and snail up-regulation

MY Lee, CY Chou, MJ Tang, MR Shen - Clinical Cancer Research, 2008 - AACR
Purpose: Acquisition of epithelial-mesenchymal transition (EMT) by primary carcinoma cells
is associated with disrupted epithelial integrity, local invasion, and ultimately metastasis …

Mitotic spindle misorientation in cancer–out of alignment and into the fire

JC Pease, JS Tirnauer - Journal of cell science, 2011 - journals.biologists.com
Mitotic spindle orientation can influence tissue organization and vice versa. Cells orient their
spindles by rotating them parallel or perpendicular to the cell–and hence the tissue–axis …

Metastasis suppressor, NDRG1, mediates its activity through signaling pathways and molecular motors

J Sun, D Zhang, DH Bae, S Sahni, P Jansson… - …, 2013 - academic.oup.com
The metastasis suppressor, N-myc downstream regulated gene 1 (NDRG1), is negatively
correlated with tumor progression in multiple neoplasms, being a promising new target for …

[HTML][HTML] Insights into therapy resistance in cervical cancer

IA George, R Chauhan, RE Dhawale, R Iyer… - Advances in Cancer …, 2022 - Elsevier
Abstract Treatment failure is one of the main hurdles in treating cervical cancer, despite
significant breakthroughs in both conventional and targeted therapy. The one-year survival …

Solute carriers (SLCs) in cancer

S El-Gebali, S Bentz, MA Hediger, P Anderle - Molecular aspects of …, 2013 - Elsevier
During tumor progression cells acquire an altered metabolism, either as a cause or as a
consequence of an increased need of energy and nutrients. All four major classes of …

Loss of breast epithelial marker hCLCA2 promotes epithelial-to-mesenchymal transition and indicates higher risk of metastasis

V Walia, Y Yu, D Cao, M Sun, JR McLean, BG Hollier… - Oncogene, 2012 - nature.com
Transition between epithelial and mesenchymal states is a feature of both normal
development and tumor progression. We report that expression of chloride channel …

Solute carriers as potential oncodrivers or suppressors: their key functions in malignant tumor formation

K Rashid, A Ahmad, L Liang, M Liu, Y Cui, T Liu - Drug discovery today, 2021 - Elsevier
Highlights•SLCs play a key part in the metabolically driven tumor growth and
metastasis.•SLCs can exert both tumor-promoting as well as suppressive functions in …